Patient‐reported disease control versus overall symptom severity as global metrics of chronic rhinosinusitis disease status

Author:

Cotter Ryan A.1ORCID,Garcia Jack T.1,Alsayed Ahmed2,Schneider Sven3,Liu David T.3ORCID,Eckl‐Dorna Julia3ORCID,Houssein Firas A.1,Boparai Robby S.4,Parail Nikhil A.1,Chu Matthew M.1,Meier Josh C.45,Alsaleh Saad2ORCID,Phillips Katie M.1ORCID,Sedaghat Ahmad R.1

Affiliation:

1. Department of Otolaryngology—Head and Neck Surgery University of Cincinnati College of Medicine Cincinnati Ohio USA

2. Department of Otolaryngology––Head and Neck Surgery College of Medicine King Saud University Riyadh Saudi Arabia

3. Department of Otorhinolaryngology Medical University of Vienna Vienna Austria

4. University of Nevada Reno School of Medicine Reno Nevada USA

5. Nevada ENT and Hearing Associates Reno Nevada USA

Abstract

AbstractBackgroundOverall symptom severity (OSS) and patient‐reported chronic rhinosinusitis (CRS) control are global measures of CRS identified as consensus, essential criteria for CRS disease control assessment. We sought to determine the functional relationship between these two metrics.MethodsUsing an international multicenter mixed‐methods design, 260 CRS patients were recruited. OSS score was measured using a visual analog scale. Patient‐reported CRS control was measured as “controlled,” “partly controlled,” and “uncontrolled.” Twelve participants underwent semi‐structured interviews to discuss OSS and patient‐reported CRS control.ResultsThe majority of interviewed participants felt OSS and patient‐reported CRS control measured different constructs—while OSS only measured symptoms, patient‐reported CRS control was more global, including not only symptom severity but also concepts such as medication usage, activity impairment, and exacerbations. Nevertheless, OSS score was strongly correlated with (ρ = 0.67, p < 0.001) and highly predictive of patient‐reported CRS control. OSS score of >4 (95% confidence interval [CI]: 1.8–4.2) had 74.7% sensitivity and 93.2% specificity in identifying patients reporting their CRS as not controlled. OSS score of >6.6 (95% CI: 4.1–7.1) had 77.0% sensitivity and 75.9% specificity in identifying patients reporting their CRS as uncontrolled. The 22‐item Sinonasal Outcome Test score was also predictive of patient‐reported CRS disease control but OSS was significantly more predictive.ConclusionsPatients conceptually view patient‐reported CRS control as a more global measure that subsumes OSS. Quantitatively, however, OSS is highly correlated with patient‐reported CRS control, possibly reflecting their redundancy. For ease of use, we recommend patient‐reported CRS control be reflected by OSS <4 for controlled, 4 ≤ OSS < 7 for partly controlled, and OSS ≥7 for uncontrolled CRS.

Publisher

Wiley

Reference28 articles.

1. Defining ‘control’ of chronic rhinosinusitis

2. Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literature

3. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study;Sedaghat AR;Rhinology,2023

4. Disease control in chronic rhinosinusitis: a qualitative study of patient perspectives;Walker V;Rhinology,2022

5. Patient‐reported chronic rhinosinusitis disease control is a valid measure of disease burden;Phillips KM;Rhinology,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3